Publications

This public summary document outlines a Stoma Product Assessment Panel decision, following a review of support garments in subgroup 9(h) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation for improvements/changes to the 2 existing Omnigon Flexima 1-piece closed products listed in subgroup 1(b) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to add a variant of the Omnigon BBraun Flexima Active 1-piece drainable pouch with a convex baseplate in subgroup 2(b) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 4 variants from the current listing of Omnigon BBraun Flexima Active from subgroup 2(b) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list the Omnigon Welland Aurum Plus urostomy in subgroup 3(a) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 4 variants from the current listing of Omnigon BBraun Flexima Active 1-piece closed pouch with a convex baseplate from subgroup 1(c) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list the Omnigon Welland Aurum Plus drainable in subgroup 2(a) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list the Omnigon Welland Aurum Plus closed in subgroup 1(b) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 2 variants from the current listing of Omnigon Pelican from subgroup 3(a) of the Stoma Appliance Scheme Schedule.

This report provides information on the medical research commercialisation landscape in Australia.

This report provides information on the 2020 evaluation of the Medical Research Future Fund’s Rapid Applied Research Translation initiative.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 15 December 2020.

This communique summarises the meeting of the Aboriginal and Torres Strait Islander Advisory Group on COVID-19 held on 14 December 2020.

This document outlines the Medicare Benefits Schedule (MBS) Taskforce’s
recommendations in response to the Ophthalmology Clinical Committee Report.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government in response to the Consumer Panel's report.

This document outlines the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in
response to the report from the Consumer Panel.

This report includes recommendations from the Optometry Services Clinical Committee, which have been revised and endorsed by the Medicare Benefits Schedule (MBS) Review Taskforce following consultation with stakeholders.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Optometry Clinical Committee report.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of Otolaryngology, Head and Neck Surgery MBS items.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the  Otolaryngology, Head and Neck Surgery Clinical
Committee (OHNSCC) report.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Aboriginal and Torres Strait Islander Health Reference Group report.

Medicare Benefits Schedule Review Taskforce Report from the Aboriginal and Torres Strait Islander Health Reference Group.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Participating
Midwives Reference Group (PMRG) report.

This report contains the recommendations the Participating Midwife Reference Group made to the MBS Review Taskforce, after public consultation.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Nurse Practitioner Reference Group report.